The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission

Growing evidence indicates that the glucagon-like peptide-1 (GLP-1) system is involved in the neurobiology of addictive behaviors, and GLP-1 analogues may be used for the treatment of alcohol use disorder (AUD). Here, we examined the effects of semaglutide, a long-acting GLP-1 analogue, on biobehavi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuong, Vicky, Farokhnia, Mehdi, Khom, Sophia, Pince, Claire L., Elvig, Sophie K., Vlkolinsky, Roman, Marchette, Renata C.N., Koob, George F., Roberto, Marisa, Vendruscolo, Leandro F., Leggio, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371247/
https://www.ncbi.nlm.nih.gov/pubmed/37192005
http://dx.doi.org/10.1172/jci.insight.170671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371247/
https://www.ncbi.nlm.nih.gov/pubmed/37192005
http://dx.doi.org/10.1172/jci.insight.170671

Ejemplares similares